SEC Filing - ReShape Lifesciences

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SABBY MANAGEMENT, LLC

(Last)

(First)

(Middle)

10 MOUNTAINVIEW ROAD

SUITE 205

(Street)

UPPER SADDLE RIVER

07458

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/15/2019

3. Issuer Name and Ticker or Trading Symbol
ReShape Lifesciences Inc. [ RSLS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,043,408	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽³⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Pre-Funded Warrant $0.01 Strike⁽¹⁾⁽²⁾⁽³⁾	11/28/2018⁽²⁾	11/28/2028⁽²⁾	Common Stock⁽²⁾	3,660,000⁽²⁾	0.01⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Warrant $1.25 Strike⁽¹⁾⁽²⁾⁽³⁾	04/03/2018⁽²⁾	04/03/2019⁽²⁾	Common Stock⁽²⁾	16,666⁽²⁾	1.25⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Warrant $1.25 Strike⁽¹⁾⁽²⁾⁽³⁾	06/21/2018⁽²⁾	12/21/2023⁽²⁾	Common Stock⁽²⁾	1,118⁽²⁾	1.25⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Warrant $1.25 Strike⁽¹⁾⁽²⁾⁽³⁾	07/12/2018⁽²⁾	01/12/2024⁽²⁾	Common Stock⁽²⁾	2,956⁽²⁾	1.25⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Warrant $1.25 Strike⁽¹⁾⁽²⁾⁽³⁾	02/03/2019⁽²⁾	02/05/2024⁽²⁾	Common Stock⁽²⁾	3,690⁽²⁾	1.25⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Warrant $1.25 Strike⁽¹⁾⁽²⁾⁽³⁾	09/20/2018⁽²⁾	09/20/2023⁽²⁾	Common Stock⁽²⁾	14,196⁽²⁾	1.25⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Warrant $1.25 Strike⁽¹⁾⁽²⁾⁽³⁾	08/16/2017⁽²⁾	08/16/2024⁽²⁾	Common Stock⁽²⁾	750⁽²⁾	1.25⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Warrant $1.25 Strike⁽¹⁾⁽²⁾⁽³⁾	06/08/2018⁽²⁾	12/08/2023⁽²⁾	Common Stock⁽²⁾	669⁽²⁾	1.25⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Warrant $1.50 Strike⁽¹⁾⁽²⁾⁽³⁾	11/28/2018⁽²⁾	11/28/2023⁽²⁾	Common Stock⁽²⁾	4,000,000⁽²⁾	1.5⁽²⁾	I⁽¹⁾⁽³⁾	See Footnotes⁽¹⁾⁽²⁾⁽³⁾

Explanation of Responses:

1. This Form 3 is being filed by Sabby Healthcare Master Fund, Ltd. ("SHMF"), Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SHMF and SVWMF. Mr. Mintz is the manager of Advisor.

2. The exercise of this security into shares is subject to a blocker, and the holder is not allowed to exercise this security into shares if as a result of such exercise the holder (in the aggregate with its affiliates) would own in excess of 4.99% of the outstanding shares (9.99% of the outstanding shares in the case of the Pre-Funded Warrant). As holder (in the aggregate with its affiliates) currently owns more than 9.99% of the outstanding shares, this security is not currently eligible for exercisse into shares.

3. The amount reported herein reflects the entire amount of Issuer's securities held by SHMF and SVWMF as of January 15, 2019. Each of Advisor and Mr. Mintz disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his indirect pecuniary interest therein, and this report shall not be deemed an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

	/s/ Robert Grundstein, COO and General Counsel of Sabby Management, LLC	01/17/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.